Boston Scientific Corporation (BSX) earnings
BSX earnings moved a median of +0.33% by the close. Quarterly and annual BSX reports and results, each read against the price at its own news timestamp. Back to the BSX overview →
33 measured BSX earnings events.
Where these BSX earnings landedvs 32 measured BSX earnings reactions
| Middle 50% of BSX earnings reactions | -0.86% to +0.89% |
|---|---|
| Median reaction (to close) | +0.33% |
| Measured reactions | 32 |
Point-in-time · zero look-ahead
Half of the 32 BSX earnings events with a measured close landed between -0.86% and +0.89%; 56% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Boston Scientific announces participation in Wells Fargo 21st Annual Healthcare Conference and conference call discussing third quarter 2026 results | Press release | +0.58% | — | |
| Form 10-Q BOSTON SCIENTIFIC CORP For: Jun 30 | SEC filing · Form 10-Q | +1.37% | +1.40% | |
| Boston Scientific announces results for second quarter 2026 | Press release | +1.80% | +7.90% | |
| Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results | Press release | +0.71% | +0.35% | |
| Form 10-Q BOSTON SCIENTIFIC CORP For: Mar 31 | SEC filing · Form 10-Q | +0.49% | -1.76% | |
| Boston Scientific announces results for first quarter 2026 | Press release | +2.48% | +3.96% | |
| Boston Scientific announces conference call discussing first quarter 2026 results | Press release | +1.09% | -1.67% | |
| Form 10-K BOSTON SCIENTIFIC CORP For: Dec 31 | SEC filing · Form 10-K | -0.52% | +0.51% | |
| Form 10-Q BOSTON SCIENTIFIC CORP For: Sep 30 | SEC filing · Form 10-Q | -1.12% | -2.14% | |
| Boston Scientific announces results for third quarter 2025 | Press release | -1.30% | +0.65% | |
| Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results | Press release | -0.63% | +1.13% | |
| Form 10-Q BOSTON SCIENTIFIC CORP For: Jun 30 | SEC filing · Form 10-Q | -0.19% | +0.78% | |
| Boston Scientific announces results for second quarter 2025 | Press release | +0.89% | +0.80% | |
| Boston Scientific announces conference call discussing second quarter 2025 results | Press release | -0.02% | -2.08% | |
| Form 10-Q BOSTON SCIENTIFIC CORP For: Mar 31 | SEC filing · Form 10-Q | -0.85% | +0.65% | |
| Boston Scientific announces results for first quarter 2025 | Press release | +1.82% | -1.08% | |
| Boston Scientific announces conference call discussing first quarter 2025 results | Press release | -0.33% | +0.84% | |
| Form 10-K BOSTON SCIENTIFIC CORP For: Dec 31 | SEC filing · Form 10-K | -0.26% | +0.30% | |
| Boston Scientific Announces Participation in the J.P. Morgan Healthcare Conference and Conference Call Discussing Fourth Quarter 2024 Results | Press release | -0.24% | -0.71% | |
| Form 10-Q BOSTON SCIENTIFIC CORP For: Sep 30 | SEC filing · Form 10-Q | +0.11% | -0.84% | |
| Boston Scientific Announces Results for Third Quarter 2024 | Press release | -0.99% | +2.87% | |
| Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results | Press release | -0.33% | +0.81% | |
| Form 10-Q BOSTON SCIENTIFIC CORP For: Jun 30 | SEC filing · Form 10-Q | -0.01% | -0.35% | |
| Boston Scientific Announces Results for Second Quarter 2024 | Press release | -1.66% | +1.07% | |
| Boston Scientific Announces Conference Call Discussing Second Quarter 2024 Results | Press release | -0.19% | -1.15% | |
| Form 10-Q BOSTON SCIENTIFIC CORP For: Mar 31 | SEC filing · Form 10-Q | -0.92% | -0.61% | |
| Boston Scientific Announces Results for First Quarter 2024 | Press release | +0.93% | -0.44% | |
| Boston Scientific Announces Conference Call Discussing First Quarter 2024 Results | Press release | +0.12% | -0.47% | |
| Form 10-K/A BOSTON SCIENTIFIC CORP For: Dec 31 | SEC filing · Form 10-K | +0.01% | +1.27% | |
| Form 10-K BOSTON SCIENTIFIC CORP For: Dec 31 | SEC filing · Form 10-K | -0.32% | -0.90% | |
| Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results | Press release | +0.45% | +0.29% | |
| Form 10-Q BOSTON SCIENTIFIC CORP For: Sep 30 | SEC filing · Form 10-Q | +0.14% | +1.08% | |
| BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR THIRD QUARTER 2023 | Press release | +0.35% | -2.24% |
Keep exploring
More BSX: analyst actions → · SEC filings → · BSX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Illumina, Inc. (ILMN) | 914 | +0.02% | 51% |
| Twist Bioscience Corporation (TWST) | 914 | -0.01% | 50% |
| Concert Pharmaceuticals, Inc. (CNCE) | 911 | 0.00% | 48% |
| TROVAGENE (TROV) | 906 | -0.52% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.